Slide 1: SecureKloud: Delivering Cloud Excellence With Trust
Slide 2: FY23 Q2 Earnings Presentation
FY23 Q2 Earnings Presentation Pioneering the Digital Transformation Journey with Platform-based Offerings November 10, 2022 Proprietary and Confidential. © 2022 SecureKloud Technologies Ltd.
Slide 3: Safe Harbor Notice
Safe Harbor Notice This presentation has been prepared by SecureKloud Technologies Ltd. solely to provide information about the Company. No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such i
Slide 4: SecureKloud Technologies is an industry-recognized global leader in the Cloud services arena
SecureKloud Technologies is an industry-recognized global leader in the Cloud services arena. Our experience in cloud consulting and servicing for highly regulated industries extends more than a decade. Our Locations Client Network Industry Verticals ✓ HQ: Chennai, India ✓ USA ✓ Healthcare & Life Sc
Slide 5: Platform-led Growth
Platform-led Growth Spearheading Platform-centric, Recurring Revenue Model Proprietary and Confidential. © 2022 SecureKloud Technologies Ltd.
Slide 6: The Arc of Transformation
Now Data Collaboration is made easy: Powering seamless data sharing and collaboration while maintaining full control of privacy in a multi-tenant environment Highly Automated AI Powering Enterprise powered & Data Analytics Blockchain Transformation: Platform: Transforming data Plug and play blockcha
Slide 7: New Solutions to Accelerate Innovation - Metaverse
New Solutions to Accelerate Innovation - Metaverse We challenge ourselves every day, to deliver excellence for our customers across all industries Strategic Partnerships $996B $22.79B $996B TAM for Global 2022 2030 Metaverse Source: GlobalData Proprietary and Confidential. © 2022 SecureKloud Technol
Slide 8: Q2 Key Updates
Q2 Key Updates Healthcare Triangle Inc., raised Launched Healthcare Triangle in approximately INR 5,152 lakhs Singapore to offer our digital (USD 6.5 million) through healthcare services across the private placement Asia Pacific region Launched Neutral Zone for Recurring revenues drug discovery in a
Slide 9: Business Highlights - new wins and expansions
Business Highlights - new wins and expansions Implemented MEDITECH Standardised cloud platform using Expanse for Chronic Care IaC (Infrastructure-as-Code) for a Management for a Primary genomics-based drug discovery Healthcare Centre enterprise Upgraded cloud platform for Executed data management an
Slide 10: Financial Highlights
Financial Highlights ✓ Revenue of INR 11,995 lakhs for the quarter; growth 37.7% YoY ✓ Healthcare and Life Science revenue of INR 9,454 lakhs for the quarter, growth 59.0% YoY ✓ Information, Communication & Technology revenue of INR 2,541 lakhs for the quarter ✓ R&D spends of INR 1,154 lakhs for the
Slide 11: Income Statement (₹ in Lakhs)
Income Statement ✓ Neutral zone related R&D spends INR 7.60 Crores ✓ Professional & Legal costs towards private placement INR (₹ in Lakhs) 1.50 Crores ✓ Additional S&M costs INR 2.10 Crores Q2 FY23 Q1 FY23 Q2 FY22 QoQ YoY Revenue 11,995 11,031 8,714 8.7% 37.7% Cost of sales 8,870 8,550 6,422 Gross P
Slide 12: Entity wise Income Statement (₹ in Lakhs)
Entity wise Income Statement (₹ in Lakhs) Q2 FY23 SK India SK Inc HTI DevCool BET HTI India SK Canada Total Revenue 249 2,143 5,212 4,145 190 - 56 11,995 Cost of sales 613 2,008 2,611 3,430 208 - - 8,870 Gross Profit (364) 135 2,601 715 (18) - 56 3,125 R&D expenses 244 (95) 1,005 - - - - 1,154 Selli
Slide 13: Balance Sheet (₹ in Lakhs)
Balance Sheet (₹ in Lakhs) Q2 FY23 FY22 Assets Property, plant and equipment and Right-of-use assets 833 894 Other intangible assets and goodwill 20,158 20,391 Trade receivables 7,323 6,682 Cash and cash equivalents 3,697 1,576 Other financial assets 361 961 Current and non-current tax assets 350 33
Slide 14: Cashflow Statement (₹ in Lakhs)
Cashflow Statement (₹ in Lakhs) Q2 FY23 FY22 Cash flow from operating activities (2,307) (6,901) Cash flow from investing activities (84) (3,715) Cash flow from financing activities 4,358 7,265 Effect of foreign currency translation adjustment 154 221 Net increase/ (decrease) in Cash and cash equiva
Slide 15: Key Metrics
Key Metrics Revenue by vertical Q2 FY23 Q1 FY23 Q2 FY22 Healthcare and Life Science 78.8% 72.3% 68.2% Information, Communication & Technology 21.2% 27.7% 31.8% Revenue mix Q2 FY23 Q1 FY23 Q2 FY22 Recurring 42.2% 42.4% 39.0% Non-Recurring 57.8% 57.6% 61.0% Revenue mix by service line Q2 FY23 Q1 FY23
Slide 16: Key Metrics
Key Metrics Client contribution to revenue Q2 FY23 Q1 FY23 Q2 FY22 Top 5 customers 62.4% 60.9% 58.1% Top 10 customers 73.6% 72.9% 71.6% Top 20 customers 81.4% 82.2% 78.7% Net debt position (₹ in lakhs) Q2 FY23 Q1 FY23 Q2 FY22 Term loans and working capital loan 7,388 8,211 5,584 Promoters 3,138 3,13
Slide 17: SecureKloud: Delivering Cloud Excellence With Trust
S=CUR=KLOUD Delivering Cloud Excellence With Trust